LIPID NANOCARRIERS FOR CANCER

Devi Raman

ISBN 10: 620616148X / ISBN 13: 9786206161486

Published by LAP LAMBERT Academic Publishing Jul 2025, 2025

About this Item

Neuware -Lipid nanocarriers are a novel drug delivery system that utilizes tiny, fat-based particles to target and treat cancer cells. These nanocarriers have shown great promise in: Targeted delivery: Directly delivering anticancer drugs to tumor sites, reducing side effects, and improving efficacy. Improved bioavailability: Enhancing the absorption and distribution of drugs, leading to better therapeutic outcomes.Enhanced therapeutic index: Maximizing the therapeutic effect while minimizing toxicity.Combination therapy: Allowing for the co-delivery of multiple drugs, targeting various aspects of cancer biology. The benefits of lipid nanocarriers include:Biocompatibility: Composed of natural lipids, reducing toxicity and immunogenicity. Flexibility: Can be engineered to deliver a wide range of anticancer agents.Scalability: Can be produced on a large scale, making them a viable option for clinical translation. Overall, lipid nanocarriers offer a promising approach for cancer treatment, providing a targeted, efficient, and safe way to deliver anticancer therapies. 56 pp. Englisch.

Seller Inventory # 9786206161486

Bibliographic Details

• Title: LIPID NANOCARRIERS FOR CANCER
• Publisher: LAP LAMBERT Academic Publishing Jul 2025
• Publication Date: 2025
• Language: English
• ISBN 10: 620616148X
• ISBN 13: 9786206161486
• Binding: Taschenbuch
• Condition: Neu
• Dimensions: 220W x 150H x 4D millimeters 220 millimeters width by 150 millimeters height by 4 millimeters depth
• Weight: 102 grams

About this title

Synopsis

Lipid nanocarriers are a novel drug delivery system that utilizes tiny, fat-based particles to target and treat cancer cells. These nanocarriers have shown great promise in: Targeted delivery: Directly delivering anticancer drugs to tumor sites, reducing side effects, and improving efficacy. Improved bioavailability: Enhancing the absorption and distribution of drugs, leading to better therapeutic outcomes.Enhanced therapeutic index: Maximizing the therapeutic effect while minimizing toxicity.Combination therapy: Allowing for the co-delivery of multiple drugs, targeting various aspects of cancer biology. The benefits of lipid nanocarriers include:Biocompatibility: Composed of natural lipids, reducing toxicity and immunogenicity. Flexibility: Can be engineered to deliver a wide range of anticancer agents.Scalability: Can be produced on a large scale, making them a viable option for clinical translation. Overall, lipid nanocarriers offer a promising approach for cancer treatment, providing a targeted, efficient, and safe way to deliver anticancer therapies.